Concepedia

Jennifer Zerfass

JZ

Statistics

Publications

4

Citations

130

H-Index

4

Active since

2007

Affiliations

Immunotope (United States)(Current)

Duke University

Jennifer Zerfass is an author at Immunotope (United States) specializing in life sciences, immunology, and immunotherapy.

Publications per year

2007–2011

4

Publications

4

ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers

Gomathinayagam Sinnathamby, Jennifer Zerfass, Julie Hafner et al. · Clinical & Experimental Immunology · 2010 · 45 citations · Full text

, , +16

Shared Immunoproteome for Ovarian Cancer Diagnostics and Immunotherapy:  Potential Theranostic Approach to Cancer

Ramila Philip, Sidhartha Murthy, Jonathan Krakover et al. · Journal of Proteome Research · 2007 · 39 citations · Full text

, , +17

Priming and Activation of Human Ovarian and Breast Cancer-specific CD8+ T Cells by Polyvalent Listeria monocytogenes-based Vaccines

Gomathinayagam Sinnathamby, Peter Lauer, Jennifer Zerfass et al. · Journal of Immunotherapy · 2009 · 32 citations

, , +17

EDDR1 is a Potential Immunotherapeutic Antigen in Ovarian, Breast, and Prostate Cancer

Gomathinayagam Sinnathamby, Jennifer Zerfass · Journal of Clinical & Cellular Immunology · 2011 · 14 citations

, , +14

1–4 of 4